Long-term survival of patients with paranasal sinus carcinoma.
The survival rate for all patients with a squamous cell carcinoma of the paranasal sinuses (n = 77) diagnosed in 1960-1985 in a population of approximately 1 million inhabitants was analysed without any selection of cases. This population is geographically restricted to the most northern part of Sweden. The 5-year survival rates of patients with T3 and T4 carcinomas were 42 and 14%, respectively (corrected survival), and the 10-year survival rates were 40 and 14%, respectively. In patients with tumours which initially were considered as resectable, the optimal treatment modality was a combination of radiotherapy and surgery.
Anniko
M
M
Department of Oto-Rhino-Laryngology, University Hospital, Umeå, Sweden.
Franzén
L
L
Löfroth
P O
PO
D002294:Carcinoma, Squamous Cell / Q000401:mortality* / Q000628:therapy; D003131:Combined Modality Therapy; D006801:Humans; D008443:Maxillary Sinus / Q000601:surgery; D008444:Maxillary Sinus Neoplasms / Q000401:mortality / Q000628:therapy; D010255:Paranasal Sinus Neoplasms / Q000401:mortality* / Q000628:therapy; D011879:Radiotherapy Dosage; D015996:Survival Rate; D013548:Sweden / Q000453:epidemiology; D013997:Time Factors